XCLINICAL
21.1.2021 14:02:05 CET | Business Wire | Press release
XClinical, a leading vendor of eClinical software has announced a merger with France-based Carenity, a social platform supporting patients and caregivers worldwide, and Fortress Medical Systems, the US-based vendor of Clindex®, an integrated CTMS and EDC system. All three companies are long-established, leading providers in their respective markets. The group is financed by German Private Equity firm BID Equity. Together, the three businesses will form a new, innovative data science company, powered by cutting edge technology. The group brings best in class data science and eClinical software solutions together, delivering end-to-end coverage of the clinical development process for their 150+ customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.
Biopharma, Medical Device as well as Academic sponsors and CROs worldwide will benefit from progressive and cost-efficient solutions such as feasibility studies, Real World Evidence data collection, patient recruitment, market access support in combination with EDC, CTMS, IWRS, eTMF, RBM and eCOA.
About XClinical
XClinical, a leading international provider of eClinical software solutions, has been the first acquisition in BID Equity’s Life Sciences portfolio. The company was founded 2002 in Munich, Germany with a vision to build a new EDC system leveraging CDISC standards to accelerate the database build and reduce data management programming efforts. XClinical’s Marvin is one of the world’s most established eClinical solutions, helping clinical study sponsors and CROs harness the power of their data to better manage clinical trials.
About Carenity
Carenity is a leading social platform supporting 500,000 patients and caregivers worldwide, across 1,000 chronic and rare diseases.
Through its award-winning platform and data science expertise, Carenity provides direct, timely and compliant access to patient real-world data. Founded in 2011 and headquartered in Paris, Carenity offers unique solutions for Real-World Evidence, Clinical Trial Optimization as well as Scientific Communication.
About Fortress Medical Systems
Fortress Medical Systems was founded in 1997 with the launch of Clindex®, one of the first integrated software systems designed for clinical trials. Over the years, Clindex® has been used to support medical device pharmaceutical, diagnostic and combination product studies. By working closely with their customers, the Fortress Medical team managed to grow the functionality of Clindex® so it is one of the most flexible and comprehensive systems on the market today. The client base spans the world. As a testament to the scalability of Clindex®, clients range from Fortune 500 corporations to small, start-up companies and include many contract Clinical Research Organizations as well.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210121005032/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Charted Launches ERP-Native E-invoicing Across EMEA1.9.2026 14:30:00 CEST | Press release
Expansion will bring Charted E-invoicing across Europe, supporting accounts payable operations with a fully compliant invoicing process that remains embedded inside their ERP Charted, a leading accounts payable automation software and ERP services provider, today announced the expansion of Charted E-invoicing to support multiple countries spanning Europe, including Germany, France, Norway, Sweden, the Netherlands, Denmark and Finland. Further expansion to Italy, Romania, and Poland, will take place by the end of the quarter. These countries follow the official launch of Charted E-invoicing in Belgium, in May 2026. This expansion is designed to cement Charted support for users across EMEA, ensuring companies based in the region transacting on the PEPPOL network can remain compliant while keeping their accounts payable processes embedded inside their ERP. Charted E-invoicing works as a capability within Charted Invoice AI, to receive electronic invoices directly into the AP inbox, keepin
Riskified Expands its Risk Intelligence Platform with ARIA1.9.2026 14:00:00 CEST | Press release
AI Risk Intelligence Analyst (ARIA) gives fraud teams instant answers from their order data, helping them investigate patterns, drill into trends, and act on insights directly within the Riskified Control Center Riskified (NYSE: RSKD), a global leader in ecommerce fraud detection and risk intelligence, today expanded its risk intelligence platform with ARIA (AI Risk Intelligence Analyst), a conversational AI capability built directly into the Riskified Control Center. Fraud teams today have access to vast amounts of data, but solving urgent business questions often still requires exporting files, building reports, or waiting for additional analysis. ARIA changes that by letting merchants ask questions in natural language and get answers in seconds, complete with charts and tables that support the analysis. With direct access to Riskified metrics and their own business-specific reporting logic, ARIA can investigate and quickly answer a wide range of questions within an existing workflow
Vasion® Unlocks Windows PCs on Snapdragon Adoption with Native, Driverless Printing1.9.2026 14:00:00 CEST | Press release
Eliminating One of the Last Barriers to Enterprise Windows Modernization Vasion is removing a critical barrier to modern Windows device adoption with native, driverless printing for PCs powered by Snapdragon® compute processors. The Vasion Spring 2026 release delivers a seamless, cloud-native print experience, eliminating the need for printer drivers, emulation, or parallel print environments. The collaboration with Qualcomm Technologies combines the PC ecosystem reach of Snapdragon with Vasion's print automation expertise. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901581087/en/ Vasion fully supports Windows devices powered by Snapdragon with full Internet Printing Protocol (IPP) driverless printing support, enabling IT teams to modernize device fleets without disrupting operations or rearchitecting existing environments. Vasion fully supports Windows devices powered by Snapdragon with full Internet Printing Protocol
Perma-Pipe and Welspun Announce Memorandum of Understanding to Establish Pipe Manufacturing and Coating Facilities in Jordan1.9.2026 14:00:00 CEST | Press release
Strategic Partnership to Establish Integrated Pipe Manufacturing and Coating Capabilities to Support Water, Oil & Gas, and Infrastructure Projects in Jordan and the Levant Region. Perma-Pipe International Holdings, Inc. (Nasdaq: PPIH) (“Perma-Pipe” or the “Company”), a global leader in engineered pipe solutions specialising in anti-corrosion coatings, insulation solutions, containment systems, custom fabrication and leak detection, today announced that it has signed, together with Welspun Corp Limited (“Welspun”), a Memorandum of Understanding (“MOU”) with the developers of Jordan’s National Water Carrier Project and the Government of the Hashemite Kingdom of Jordan to advance the development of pipe manufacturing and advanced coating facilities in Jordan. The parties intend to establish a joint venture to support the development and operation of these facilities. Transaction Description Under the terms of the MOU, Perma-Pipe and Welspun have partnered to establish an integrated pipe m
Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 20261.9.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the 2026 Cantor Global Healthcare Conference on September 9, 2026 and will participate in a fireside chat at 3:20pm ET and a panel entitled “PSYCH! Accessing The New Wave of Psychedelics” at 4:30pm ET. A live audio webcast of the fireside chat will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways We believe mental health patients deserve the possibility of a better future. Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom